Tag Archives: BIO Events

Voting Opens for Everyday Superhero Contest

BIO-InternationalConvention_Graphic_115x176_v3

Earlier this month, members of the biotech community nominated their best and brightest colleagues who are striving to heal, fuel, and feed the world through groundbreaking innovation. Now it is your turn to vote for your favorite BIO Superhero in each of the three categories: Biotech/Pharma, Patient/Patient Group, and University/Research Institution. One vote per email address, per day will be strictly enforced. The individuals with the most votes in each category will win a complimentary Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Upcoming Webinar: The Future of Partnering

Partnering-HP-Banner

We’ve talked before about the new and improved BIO One-on-One™ partnering system coming for BIO 2015. To give you a sneak peak at the new system, BIO and INOVA are co-hosting a webinar on Thursday, March 19th from 11:00 am – 11:45 am EDT. To RSVP for tomorrow’s webinar, please click here. Find more information about BIO One-on-One Partnering, including upcoming webinars and training events, at convention.bio.org/partner. INOVA and BIO have teamed up to create Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Session Recap: “Trust Your Gut” – Therapeutic Opportunities from the Microbiome

Kaylee_dna_115x76

Tuesday at the BIO CEO & Investor Conference kicked off with a Therapeutic Workshop titled, “Trust Your Gut” – Therapeutic Opportunities from the Microbiome. The panel was moderated by Mark Breidenbach, PhD, Equity Research Group, H.C. Wainwright & Co. The panelists were: Martin J. Blaser, MD, Muriel and George Singer Professor of Medicine, Professor of Microbiology, Director, Human Microbiome Program, New York University Langone Medical Center Karim Dabbagh, PhD, Chief Scientific Officer, Second Genome Michael Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Session Recap: Digital Health—Early Successes for Investors and Biotech R&D Productivity

shutterstock_27160801

Digital health has the potential to improve the life science industry by combining traditional and novel medicines with digital technologies, enabling the life sciences to become more patient-centered as well as accelerating product discovery. There is growing interest in digital health among investors as new data and technologies become available that fill unmet needs in the marketplace. At the 17th Annual BIO CEO & Investor Conference, a panel of digital health experts came together to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Investor Forum Closing Plenary: How Fragile is the Biotech Rally After Five Positive Years?

2

Last week’s 13th Annual BIO Investor Forum closed on Wednesday with a plenary session asking, “How fragile is the biotech rally after five positive years?” Moderated by Todd Foley, Managing Director, MPM Capital, the panel included: Rachel King, CEO, GlycoMimetics and Chair, BIO Ellen Lubman, VP Strategy and Innovation, Forest Laboratories Vijay Murthy, Director, Ventures and Early Stage Collaborations, AbbVie Michael A. Margolis, RPh, Managing Director, ROTH Capital Partners Doug Fambrough, PhD, CEO, Dicerna Pharmaceuticals Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,